Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GERN |
---|---|---|
09:32 ET | 121458 | 4.94 |
09:34 ET | 45278 | 4.905 |
09:36 ET | 31363 | 4.9 |
09:38 ET | 85789 | 4.9 |
09:39 ET | 27812 | 4.9288 |
09:41 ET | 44739 | 4.93 |
09:43 ET | 38374 | 4.935 |
09:45 ET | 7810 | 4.935 |
09:48 ET | 51081 | 4.875 |
09:50 ET | 24599 | 4.86 |
09:52 ET | 45948 | 4.845 |
09:54 ET | 46718 | 4.8325 |
09:56 ET | 51795 | 4.8775 |
09:57 ET | 18802 | 4.875 |
09:59 ET | 54836 | 4.8604 |
10:01 ET | 30738 | 4.85 |
10:03 ET | 25658 | 4.835 |
10:06 ET | 34808 | 4.84 |
10:08 ET | 52222 | 4.86 |
10:10 ET | 17510 | 4.845 |
10:12 ET | 11216 | 4.85 |
10:14 ET | 44391 | 4.835 |
10:15 ET | 19414 | 4.85 |
10:17 ET | 9326 | 4.845 |
10:19 ET | 36472 | 4.85 |
10:21 ET | 29119 | 4.8501 |
10:24 ET | 19405 | 4.87 |
10:26 ET | 16197 | 4.87 |
10:28 ET | 22914 | 4.875 |
10:30 ET | 20857 | 4.875 |
10:32 ET | 53506 | 4.88 |
10:33 ET | 22485 | 4.89 |
10:35 ET | 47602 | 4.8812 |
10:37 ET | 76857 | 4.865 |
10:39 ET | 5987 | 4.87 |
10:42 ET | 25620 | 4.8888 |
10:44 ET | 21441 | 4.89 |
10:46 ET | 40724 | 4.91 |
10:48 ET | 106659 | 4.94 |
10:50 ET | 21171 | 4.9431 |
10:51 ET | 696746 | 4.93 |
10:53 ET | 57372 | 4.95 |
10:55 ET | 12978 | 4.96 |
10:57 ET | 42948 | 4.965 |
11:00 ET | 120365 | 4.9985 |
11:02 ET | 121917 | 5.01 |
11:04 ET | 344146 | 5.015 |
11:06 ET | 24502 | 5.0175 |
11:08 ET | 55419 | 4.985 |
11:09 ET | 42320 | 4.975 |
11:11 ET | 19924 | 4.965 |
11:13 ET | 102655 | 4.98 |
11:15 ET | 32609 | 4.97 |
11:18 ET | 8959 | 4.97 |
11:20 ET | 130195 | 4.9301 |
11:22 ET | 6855 | 4.93 |
11:24 ET | 24893 | 4.92 |
11:26 ET | 12863 | 4.915 |
11:27 ET | 40371 | 4.895 |
11:29 ET | 10041 | 4.88 |
11:31 ET | 14739 | 4.9 |
11:33 ET | 11865 | 4.9 |
11:36 ET | 85812 | 4.88 |
11:38 ET | 55317 | 4.865 |
11:40 ET | 3556 | 4.86 |
11:42 ET | 43256 | 4.855 |
11:44 ET | 23774 | 4.87 |
11:45 ET | 12736 | 4.86 |
11:47 ET | 156396 | 4.855 |
11:49 ET | 25235 | 4.8401 |
11:51 ET | 19614 | 4.87 |
11:54 ET | 19933 | 4.8499 |
11:56 ET | 5380 | 4.845 |
11:58 ET | 4653 | 4.85 |
12:00 ET | 16983 | 4.855 |
12:02 ET | 20645 | 4.84 |
12:03 ET | 13476 | 4.835 |
12:05 ET | 18998 | 4.825 |
12:07 ET | 22495 | 4.856 |
12:09 ET | 7662 | 4.87 |
12:12 ET | 35665 | 4.8599 |
12:14 ET | 5405 | 4.85 |
12:16 ET | 11100 | 4.85 |
12:18 ET | 62228 | 4.8499 |
12:20 ET | 2445 | 4.845 |
12:21 ET | 7496 | 4.845 |
12:23 ET | 3310 | 4.8499 |
12:25 ET | 48726 | 4.85 |
12:27 ET | 41246 | 4.835 |
12:30 ET | 29606 | 4.84 |
12:32 ET | 13471 | 4.84 |
12:34 ET | 29483 | 4.825 |
12:36 ET | 52326 | 4.83 |
12:38 ET | 14242 | 4.84 |
12:39 ET | 5306 | 4.8488 |
12:41 ET | 2856 | 4.85 |
12:43 ET | 2625 | 4.845 |
12:45 ET | 28900 | 4.8401 |
12:48 ET | 13317 | 4.845 |
12:50 ET | 32104 | 4.845 |
12:52 ET | 16428 | 4.845 |
12:54 ET | 18280 | 4.85 |
12:56 ET | 3862 | 4.845 |
12:57 ET | 6700 | 4.85 |
12:59 ET | 97814 | 4.855 |
01:01 ET | 2800 | 4.86 |
01:03 ET | 8700 | 4.85 |
01:06 ET | 7800 | 4.86 |
01:08 ET | 18911 | 4.88 |
01:10 ET | 30998 | 4.875 |
01:12 ET | 28082 | 4.865 |
01:14 ET | 24189 | 4.865 |
01:15 ET | 1900 | 4.865 |
01:17 ET | 10642 | 4.875 |
01:19 ET | 5400 | 4.88 |
01:21 ET | 15101 | 4.88 |
01:24 ET | 11012 | 4.87 |
01:26 ET | 29123 | 4.875 |
01:28 ET | 3522 | 4.88 |
01:30 ET | 7522 | 4.89 |
01:32 ET | 6283 | 4.8899 |
01:33 ET | 32471 | 4.9 |
01:35 ET | 18565 | 4.8999 |
01:37 ET | 16805 | 4.89 |
01:39 ET | 17282 | 4.875 |
01:42 ET | 24355 | 4.87 |
01:44 ET | 30083 | 4.87 |
01:46 ET | 13672 | 4.88 |
01:48 ET | 2782 | 4.875 |
01:50 ET | 2777 | 4.875 |
01:51 ET | 8054 | 4.87 |
01:53 ET | 3314 | 4.865 |
01:55 ET | 65642 | 4.86 |
01:57 ET | 66492 | 4.865 |
02:00 ET | 46306 | 4.86 |
02:02 ET | 5721 | 4.86 |
02:04 ET | 67257 | 4.87 |
02:06 ET | 65923 | 4.895 |
02:08 ET | 30615 | 4.895 |
02:09 ET | 19117 | 4.885 |
02:11 ET | 6883 | 4.8801 |
02:13 ET | 30494 | 4.885 |
02:15 ET | 8108 | 4.89 |
02:18 ET | 24111 | 4.875 |
02:20 ET | 22832 | 4.89 |
02:22 ET | 26717 | 4.89 |
02:24 ET | 25177 | 4.88 |
02:26 ET | 36513 | 4.875 |
02:27 ET | 52873 | 4.89 |
02:29 ET | 19627 | 4.875 |
02:31 ET | 6802 | 4.88 |
02:33 ET | 13934 | 4.88 |
02:36 ET | 17075 | 4.89 |
02:38 ET | 19947 | 4.88 |
02:40 ET | 12767 | 4.88 |
02:42 ET | 7600 | 4.88 |
02:44 ET | 6122 | 4.875 |
02:45 ET | 35196 | 4.88 |
02:47 ET | 36438 | 4.87 |
02:49 ET | 10477 | 4.865 |
02:51 ET | 21375 | 4.875 |
02:54 ET | 6166 | 4.88 |
02:56 ET | 9496 | 4.88 |
02:58 ET | 15160 | 4.885 |
03:00 ET | 6311 | 4.89 |
03:02 ET | 7367 | 4.89 |
03:03 ET | 9073 | 4.885 |
03:05 ET | 11360 | 4.89 |
03:07 ET | 68650 | 4.9175 |
03:09 ET | 33643 | 4.8941 |
03:12 ET | 16406 | 4.89 |
03:14 ET | 13270 | 4.89 |
03:16 ET | 10591 | 4.885 |
03:18 ET | 31464 | 4.865 |
03:20 ET | 5324 | 4.87 |
03:21 ET | 45899 | 4.865 |
03:23 ET | 31523 | 4.8649 |
03:25 ET | 6491 | 4.865 |
03:27 ET | 16058 | 4.875 |
03:30 ET | 16934 | 4.87 |
03:32 ET | 55472 | 4.89 |
03:34 ET | 33676 | 4.885 |
03:36 ET | 34217 | 4.875 |
03:38 ET | 24778 | 4.88 |
03:39 ET | 32675 | 4.885 |
03:41 ET | 35687 | 4.885 |
03:43 ET | 24956 | 4.875 |
03:45 ET | 16513 | 4.875 |
03:48 ET | 16697 | 4.875 |
03:50 ET | 52113 | 4.89 |
03:52 ET | 79116 | 4.9 |
03:54 ET | 75921 | 4.895 |
03:56 ET | 222777 | 4.865 |
03:57 ET | 128842 | 4.87 |
03:59 ET | 1537147 | 4.87 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Geron Corp | 2.9B | -14.1x | --- |
SpringWorks Therapeutics Inc | 2.9B | -7.5x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.7x | --- |
Biohaven Ltd | 3.0B | -5.0x | --- |
Structure Therapeutics Inc | 2.7B | -20.8x | --- |
IDEAYA Biosciences Inc | 2.9B | -19.1x | --- |
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | 5,554.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.